Friday, July 10, 2026

pharma · Primary Brain Tumor · Hepatocellular Carcinoma

Guerbet

Guerbet trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

VILLEPINTE, FR HQ
1926 Founded
2,465 Employees
EMA registrant Type
Company details
Status
Public
HQ
VILLEPINTE, FR
Founded
1926
Employees
2,465
Programs
4
Drugs
5
Patents
0
Intelligence · Clinical Trials

Guerbet clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Guerbet programs — each row shows trial ID, program name, phase, status, and indication.

Guerbet trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Guerbet.

  1. GDX-102/GDX-44-017 — Phase 3

    Clinical update
  2. Dotarem® — Approved

    Clinical update
  3. Gadoterate meglumine — Approved

    Clinical update
  4. Gadoxetate disodium — Approved

    Clinical update

Trial registry

4 studies